Federico Mingozzi: Assessing and modulating immune responses to AAV vectors in humans

Federico Mingozzi: Assessing and modulating immune responses to AAV vectors in humans

F. Mingozzi - Overcoming immune responses to AAV vectorsПодробнее

F. Mingozzi - Overcoming immune responses to AAV vectors

Immunogenicity of AAV Vectors and Transgenes - Roland HerzogПодробнее

Immunogenicity of AAV Vectors and Transgenes - Roland Herzog

Model Informed Drug Development Approaches for Immunogenicity Assessments WorkshopПодробнее

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

ESGCT 2017 Education Day - Federico MingozziПодробнее

ESGCT 2017 Education Day - Federico Mingozzi

Mechanisms of HMO in modulating immune responses, EAACI 2023Подробнее

Mechanisms of HMO in modulating immune responses, EAACI 2023

E. Ayuso - Unraveling mechanisms and biology of recombinant AAV vectors produced in insect cellsПодробнее

E. Ayuso - Unraveling mechanisms and biology of recombinant AAV vectors produced in insect cells

MODULATING IMMUNITY. SUPPORTING BODY’S REACTIONSПодробнее

MODULATING IMMUNITY. SUPPORTING BODY’S REACTIONS

Long-term Vector Genome Outcomes and Immunogenicity of AAV FVIII Gene Transfer in Hemophilia AПодробнее

Long-term Vector Genome Outcomes and Immunogenicity of AAV FVIII Gene Transfer in Hemophilia A

Immunogenic Response against Gene therapy: rAAV (recombinant Adeno-associated virus) #Code: 195Подробнее

Immunogenic Response against Gene therapy: rAAV (recombinant Adeno-associated virus) #Code: 195

Reducing the Immunogenicity of AAV through Engineering the Vector - George ChurchПодробнее

Reducing the Immunogenicity of AAV through Engineering the Vector - George Church

FirstThought Focus: Adeno-Associated Virus (AAV) Vectors in Gene Therapies with Guangping Gao, PhDПодробнее

FirstThought Focus: Adeno-Associated Virus (AAV) Vectors in Gene Therapies with Guangping Gao, PhD

Modulation of Immune Responses and Clinical Outcomes with Longer-Term OIT | 2020 Research RetreatПодробнее

Modulation of Immune Responses and Clinical Outcomes with Longer-Term OIT | 2020 Research Retreat

Overview of Preexisting Antibody Testing Prior to AAV Gene Therapy presented by Sarepta TherapeuticsПодробнее

Overview of Preexisting Antibody Testing Prior to AAV Gene Therapy presented by Sarepta Therapeutics

Model Informed Drug Development Approaches for Immunogenicity Assessments WorkshopПодробнее

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Популярное